David D Waters Selected Research

Secondary Prevention

2/2017	Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
1/2016	Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
1/2015	Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore.
4/2012	Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study.
11/2002	Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David D Waters Research Topics

Disease

33	Coronary Disease (Coronary Heart Disease) 01/2024 - 11/2002
21	Myocardial Infarction 01/2024 - 09/2002
21	Stroke (Strokes) 01/2021 - 09/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 05/2004
14	Hypertension (High Blood Pressure) 02/2017 - 04/2002
12	Atherosclerosis 12/2014 - 04/2002
11	Inflammation (Inflammations) 11/2020 - 04/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 04/2002
9	Acute Coronary Syndrome 10/2022 - 09/2002
9	Heart Failure 12/2019 - 10/2006
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2014 - 09/2006
7	Type 2 Diabetes Mellitus (MODY) 01/2024 - 04/2011
7	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2002
7	Diabetes Mellitus 01/2018 - 06/2011
4	Body Weight (Weight, Body) 11/2018 - 05/2014
4	Dyslipidemias (Dyslipidemia) 09/2012 - 11/2009
4	Hypercholesterolemia 03/2010 - 04/2002
3	HIV Infections (HIV Infection) 12/2019 - 04/2004
3	Insulin Resistance 11/2016 - 07/2004
3	Unstable Angina 10/2009 - 01/2002
2	Pneumonia (Pneumonitis) 01/2021 - 12/2019
2	Gout 01/2021 - 12/2019
2	Pericarditis 01/2021 - 12/2019
2	Hypertriglyceridemia 01/2019 - 06/2008
2	Chronic Renal Insufficiency 01/2018 - 05/2009
2	Atherosclerotic Plaque (Atheroma) 12/2014 - 03/2006
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2014 - 03/2010
2	Weight Loss (Weight Reduction) 11/2012 - 06/2011
2	Aortic Dissection 10/2011 - 04/2002
2	Alzheimer Disease (Alzheimer's Disease) 03/2010 - 03/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2009 - 09/2002
2	Disease Progression 01/2008 - 08/2005
2	Hemorrhagic Stroke 11/2006 - 09/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	COVID-19 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Diarrhea 12/2019
1	Chronic Disease (Chronic Diseases) 12/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2019
1	Peripheral Arterial Disease 12/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2017

Drug/Important Bio-Agent (IBA)

39	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 04/2002
33	Atorvastatin (Lipitor)FDA Link 01/2019 - 09/2002
27	LipidsIBA 01/2019 - 04/2002
18	Trinitrotoluene (TNT)IBA 01/2019 - 09/2006
16	LDL CholesterolIBA 01/2019 - 04/2004
11	CholesterolIBA 01/2019 - 09/2002
10	oxidized low density lipoproteinIBA 01/2018 - 11/2006
9	Triglycerides (Triacylglycerol)IBA 03/2018 - 08/2009
8	Simvastatin (Zocor)FDA LinkGeneric 04/2016 - 04/2002
8	Estrogens (Estrogen)FDA Link 06/2008 - 01/2002
7	Biomarkers (Surrogate Marker)IBA 01/2016 - 10/2006
6	Colchicine FDA LinkGeneric 01/2024 - 12/2019
6	HDL CholesterolIBA 03/2018 - 06/2008
6	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 07/2004
5	Lipoproteins (Lipoprotein)IBA 08/2014 - 01/2008
5	VitaminsIBA 06/2008 - 11/2002
4	LDL Lipoproteins (beta Lipoproteins)IBA 07/2016 - 04/2005
4	Insulin (Novolin)FDA Link 01/2015 - 07/2004
3	ApolipoproteinsIBA 08/2014 - 08/2009
3	Blood Glucose (Blood Sugar)IBA 04/2014 - 04/2011
3	C-Reactive ProteinIBA 01/2014 - 12/2004
3	SmokeIBA 06/2012 - 03/2007
3	Cocaine (Cocaine HCl)IBA 10/2011 - 04/2002
3	Adenosine Triphosphate (ATP)IBA 11/2010 - 09/2006
3	EnzymesIBA 02/2009 - 04/2002
3	AntioxidantsIBA 01/2008 - 11/2002
3	Hormones (Hormone)IBA 01/2008 - 07/2004
2	dalcetrapibIBA 10/2022 - 01/2020
2	Cholesterol Ester Transfer ProteinsIBA 01/2020 - 01/2018
2	SubtilisinIBA 01/2018 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2015 - 04/2002
2	Apolipoproteins B (ApoB)IBA 08/2014 - 02/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2014 - 05/2004
2	Niacin (Nicotinic Acid)FDA LinkGeneric 04/2014 - 11/2012
2	Phospholipases (Phospholipase)IBA 02/2012 - 02/2009
2	Secretory Phospholipases A2IBA 02/2012 - 02/2009
2	varespladib methylIBA 02/2012 - 02/2009
2	torcetrapibIBA 08/2011 - 11/2007
2	Pravastatin (Pravachol)FDA LinkGeneric 10/2009 - 04/2002
2	Crack CocaineIBA 03/2007 - 04/2002
2	fibrin fragment D (D-dimer)IBA 12/2004 - 05/2004
2	Fibrinogen (Factor I)FDA Link 12/2004 - 05/2004
2	Progestins (Progestagens)IBA 07/2004 - 09/2003
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	P-2 (P 2)IBA 01/2021
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2020
1	fibroblast growth factor 21IBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	lipoprotein cholesterolIBA 01/2018
1	Lipoprotein(a)IBA 01/2018
1	Illicit Drugs (Recreational Drugs)IBA 11/2017

Therapy/Procedure

35	Therapeutics 10/2022 - 01/2002
5	Secondary Prevention 02/2017 - 11/2002
2	Art Therapy 01/2019 - 11/2017
2	Resuscitation 04/2012 - 04/2005
2	Patient Readmission 10/2009 - 09/2002
1	Time-to-Treatment 11/2020
1	Precision Medicine 01/2020